Literature DB >> 17428654

p73: a chiaroscuro gene in cancer.

Mirko Marabese1, Faina Vikhanskaya, Massimo Broggini.   

Abstract

p73 is a member of the p53 family which is gaining increasing importance in the field of cancer. Its structural homology with p53 led to the assumption that it could act as a new tumour suppressor gene. Increasing knowledge of its function, however, has cast doubts on this role. A particularly interesting characteristic of p73 is that the cell contains different isoforms with distinct and sometimes opposite functions. Evidence in the last few years clearly indicates that p73 does share some activities with p53 but also that it has some distinct functions. This review focuses on p73's role in the development and progression of cancer, analysing the gene structure and regulation and discussing similarities with p53 and differences. Recent results obtained with specific detection methods on the levels and functions of the different isoforms in tumours are also discussed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17428654     DOI: 10.1016/j.ejca.2007.01.042

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  17 in total

1.  Molecular and cellular pathways associated with chromosome 1p deletions during colon carcinogenesis.

Authors:  Claire M Payne; Cheray Crowley-Skillicorn; Carol Bernstein; Hana Holubec; Harris Bernstein
Journal:  Clin Exp Gastroenterol       Date:  2011-05-03

2.  Protein expression following gamma-irradiation relevant to growth arrest and apoptosis in colon cancer cells.

Authors:  Daniella Pfeifer; Asa Wallin; Birgitta Holmlund; Xiao-Feng Sun
Journal:  J Cancer Res Clin Oncol       Date:  2009-06-06       Impact factor: 4.553

3.  The association between non-Hodgkin lymphoma and methylation of p73.

Authors:  Jing-Hong Pei; Sai-Qun Luo; Yan Zhong; Jiang-Hua Chen; Hua-Wu Xiao; Wei-Xin Hu
Journal:  Tumour Biol       Date:  2011-08-03

Review 4.  Impact of p73 gene polymorphism on cancer susceptibility: a meta analysis.

Authors:  Yixuan Liu; Weiwei Dong; Quan Mou; Yuxin Leng; Lu Zhang; Liping Duan
Journal:  Int J Clin Exp Pathol       Date:  2014-09-15

5.  Association of p73 G4C14-to-A4T14 polymorphism with lung cancer risk.

Authors:  Hua Liu; Yuli Liang; Hua Liao; Lanying Li; Hongyun Wang
Journal:  Tumour Biol       Date:  2014-06-19

6.  Combined analysis of the association between p73 G4C14-to-A4T14 polymorphisms and cancer risk.

Authors:  Lan Wang; Rui Gao; Long Yu
Journal:  Mol Biol Rep       Date:  2011-05-27       Impact factor: 2.316

7.  TAp73alpha protects small cell lung carcinoma cells from caspase-2 induced mitochondrial mediated apoptotic cell death.

Authors:  Naveen Muppani; Ulrika Nyman; Bertrand Joseph
Journal:  Oncotarget       Date:  2011-12

8.  Significant associations of mismatch repair gene polymorphisms with clinical outcome of pancreatic cancer.

Authors:  Xiaoqun Dong; Li Jiao; Yanan Li; Douglas B Evans; Huamin Wang; Kenneth R Hess; James L Abbruzzese; Donghui Li
Journal:  J Clin Oncol       Date:  2009-02-23       Impact factor: 44.544

9.  ∆Np73beta induces caveolin-1 in human non-small cell lung cancer cell line H1299.

Authors:  Elisa Caiola; Eleonora Marrazzo; Simona Alesci; Massimo Broggini; Mirko Marabese
Journal:  Tumour Biol       Date:  2015-09-04

10.  P19 H-ras induces G1/S phase delay maintaining cells in a reversible quiescence state.

Authors:  Maria Camats; Mariette Kokolo; Kate J Heesom; Michael Ladomery; Montse Bach-Elias
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.